Skip to main content

Table 1 Baseline patient characteristics and test results

From: Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome

Characteristic Pre-implementation (n = 26) Post-implementation (n = 11) p-value
Median age at first visit, years (range) 43.5 (16–82) 52 (5–85) 0.316
Sex (%)
 Male 17 (65.4) 7 (63.6)  
 Female 9 (34.6) 4 (36.4) 1.000
Strongyloides serological test (%)
 Positive 20 (76.9) 9 (81.8)  
 Indeterminate 5 (19.2) 2 (18.2)  
 Negative 1 (3.9) 0 (0.0) 1.000
Stool ova and parasite test (%)
 Larvae detected 5 (19.2) 3 (27.3)  
 Negative 16 (61.6) 5 (45.4)  
 Not tested 5 (19.2) 3 (27.3) 0.694
Eosinophiliac (%)
 Median eosinophil count (bil/L) 0.20a 0.38b 0.930
 Positive 9 (34.6) 4 (36.4)  
 Negative 16 (61.5) 6 (54.5)  
 Not tested 1 (3.9) 1 (9.1) 0.857
Type of infectiond (%)
 Simple intestinal 25 (96.1) 8 (72.7)  
 Hyperinfection 1 (3.9) 3 (27.3) 0.070
  1. aOne patient with no eosinophil value
  2. bTwo patients with no eosinophil values
  3. ceosinophil count > 0.4 × 109/L
  4. das defined by the CATMAT guidelines [4]